Synapse - Charles Rudin

Results (166)

Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions

Journal Article

Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma

Journal Article

Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Targeting germline- and tumor-associated nucleotide excision repair defects in cancer

Journal Article

Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer

Journal Article

Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine

Meeting Abstract

Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer

Journal Article

Schoenfeld, A.; Bandlamudi, C.; Lavery, J. A.; Montecalvo, J.; Namakydoust, A.; Rizvi, H.; Egger, J.; Concepcion, C. P.; Paul, S.; Arcila, M. E.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer

Meeting Abstract

Korsen, J.; Kalidindi, T.; Khitrov, S.; Khuram, H.; Piorier, J.; Rudin, C.; Chen, Y.; Pillarsetty, N. V. K.; Lewis, J.
Journal of Nuclear Medicine (2020)

Fulltext@MSK | Save

MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer

Meeting Abstract

Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

COVID-19 in patients with lung cancer

Journal Article

Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; McCarthy, C. G.; Falcon, C. J.; Schoenfeld, A. J.; Arbour, K. C.; more...
Annals of Oncology (2020)

Fulltext@MSK | Save